Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Molecular-Guided Therapy for Childhood Cancer

NCT02162732

Conditions
Adenocarcinoma, Brain Diseases, Brain Neoplasms, +65 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View all 19 locations
View Trial Details
Completed

Study of DF9001 in Patients With Advanced Solid Tumors

NCT05597839

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UC Irvine Medical Center Irvine, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 17 locations
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Completed

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

NCT03914794

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Associated Medical Professionals Urology Syracuse, New York, United States
  • Midlantic Urology Bala-Cynwyd, Pennsylvania, United States
View Trial Details
Completed

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

NCT03075423

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Gent University Hospital (Universitair Ziekenhuis Gent) Ghent, Belgium
  • University Hospital Hradec Králové Hradec Králové, Czechia
  • Thomayer Hospital Prague, Czechia
  • Centre Hospitalier Universitaire de Bordeaux Bordeaux, France
View all 30 locations
View Trial Details

Related conditions